Rocket Lab (RKLB) stocks trade near $101.65 following record first-quarter 2026 results, with Wall Street analyst price targets spanning from a $76 bear case to Morgan Stanley's $293 bull case. In Q1 2026, the company reported revenue of $200.35 million, with its Space Systems segment generating $136.7 million (68% of total revenue) while the Launch business contributed $63.7 million. The wide 285% gap in analyst targets reflects disagreement over whether investors are buying a launch-focused stock dependent on the Neutron rocket's fourth-quarter 2026 debut, or a vertically integrated space-infrastructure business with a contracted backlog exceeding $2.2 billion. Chief executive Peter Beck stated that "Neutron is certainly mission enabling, but it's not mission critical," positioning the company's Space Systems segment and the $8 billion Iridium acquisition as core value drivers. The stock reached an all-time high of $151 on May 27, 2026, before volatility around the Iridium deal.
Rocket Lab reported record revenue of $200.35 million in the first quarter of 2026, with a net loss narrowing to $45.02 million. The Space Systems segment generated $136.7 million, representing roughly 68% of the top line, while the Launch business contributed $63.7 million. The company's contracted backlog exceeded $2.2 billion, marking a sharp year-on-year rise. Rocket Lab closed what it described as the largest launch contract in its history during the quarter, a bulk purchase of Neutron and Electron flights from an undisclosed customer. The company sold more launches in Q1 2026 than in all of 2025, with a launch manifest of more than 70 contracted missions. Beck stated on the earnings call that "demand is just not one of [the things I worry about]. The backlog is super healthy for a number of years."
Analyst 12-month price targets on Rocket Lab stocks cluster around a consensus of $108 to $113, with a Street high near $150 and a low of $76. Morgan Stanley has set a bull-case scenario target of $293. The consensus rating across 17 analysts is Buy, with 53% rating the stock a Strong Buy. The current trading price near $101.65 sits below the May 27, 2026 all-time high of $151. The $293 bull case and the $76 bear case represent two different valuations based on whether the market prices Rocket Lab as a launch-dependent company or as a space-systems business with recurring revenue streams. The stock experienced volatility following the announcement of the $8 billion agreement to acquire satellite operator Iridium.
The bullish argument centers on Rocket Lab's contracted backlog exceeding $2.2 billion and the Space Systems segment representing roughly two-thirds of revenue. The company sold more launches in a single quarter than in an entire prior year, indicating the order book is filling faster than the company can execute flights. Rocket Lab flagged growing national-security and defense demand alongside commercial backlog in Q1, with Beck describing overall demand as "super healthy" as defense and Neutron orders build. The Electron rocket has achieved more than 50 successful flights. Morgan Stanley's $293 bull case is based on a scenario where the Neutron rocket, a reusable medium-lift vehicle aimed at the market SpaceX's Falcon 9 dominates, flies successfully and proves reusable. The $8 billion Iridium acquisition positions Rocket Lab to own recurring service revenue in addition to launch and manufacturing revenue.
Rocket Lab posted a net loss of $45.02 million in Q1 2026 despite record revenue, indicating the company remains loss-making while pouring capital into Neutron development and the $8 billion Iridium acquisition. The bear case for a $76 price target is based on execution risks including a potential Neutron timeline slip, integration challenges from the Iridium deal, and rising competition from SpaceX's Falcon 9 and new launch entrants. A delay in the Neutron debut from the targeted Q4 2026 timeline into 2027 would deflate the momentum premium that carried the stock to $151. Beck's statement that Neutron is "not mission critical" and that other value drivers are "needle moving for the company in the next 12 to 24 months" creates a gap between the narrative price and operational reality. The stock's high-beta behavior reflects its dependence on capital markets staying friendly during the buildout phase.
Rocket Lab is targeting a first Neutron launch in the fourth quarter of 2026, which management describes as "on track." The timeline depends on the Archimedes engine passing a series of qualification tests that Beck described as "nasty." Beck framed the reusability challenge with the statement: "If we just had to go up, it's super easy, we'd be in orbit by now. But the reality is, it's just as important to go up as it is to come back down and be reusable again." Reusability is the technical hurdle that determines whether Neutron can convert from a cost center into a margin machine. A successful, on-time Q4 2026 debut with a clean demonstration of reusability is the event that could open the path toward triple-digit bull targets by converting Rocket Lab from a small-launch specialist into a Falcon 9 challenger.
What is the Rocket Lab (RKLB) stock price target range from analysts?
Analyst 12-month targets on Rocket Lab stocks cluster around a consensus of $108 to $113, with a Street high near $150 and a low of $76, according to public.com and MarketBeat. Morgan Stanley has set a bull-case scenario target of $293. The consensus rating across 17 analysts is Buy, with 53% rating the stock a Strong Buy.
What were Rocket Lab's Q1 2026 financial results?
Rocket Lab reported record revenue of $200.35 million in Q1 2026, with a net loss of $45.02 million. The Space Systems segment generated $136.7 million (68% of revenue) while the Launch business contributed $63.7 million. The company's contracted backlog exceeded $2.2 billion, and it sold more launches in Q1 2026 than in all of 2025.
When is Rocket Lab's Neutron rocket scheduled to launch?
Rocket Lab is targeting a first Neutron launch in the fourth quarter of 2026, which management describes as "on track." The timeline depends on the Archimedes engine passing qualification tests. Chief executive Peter Beck stated that "Neutron is certainly mission enabling, but not mission critical" to the company's overall business strategy.
Related News
Nebius (NBIS) Price Targets Span $144-$380 Amid Financing Risk Debate
Apple Stocks Hit Record High on Low-Cost AI Strategy in 2026
nLIGHT Stocks Eye Best Week in Year After $627M Defense Contract Win
Cathie Wood's ARK Buys $7M SpaceX Stocks After IPO Decline
Rocket Lab Stocks Rise As Analyst Names Company Top SpaceX Rival